Aurore Devocelle

618 total citations
15 papers, 488 citations indexed

About

Aurore Devocelle is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Aurore Devocelle has authored 15 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Aurore Devocelle's work include Immune Cell Function and Interaction (9 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (3 papers). Aurore Devocelle is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (3 papers). Aurore Devocelle collaborates with scholars based in France, Italy and China. Aurore Devocelle's co-authors include Julien Giron‐Michel, Bruno Azzarone, Bernard Charpentier, Pierre Eid, Aimé Vázquez, Silvano Ferrini, Salem Chouaı̈b, Christophe Desterke, Lola Lecru and Arnaud François and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Aurore Devocelle

15 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurore Devocelle France 12 175 149 134 73 49 15 488
Jiao Wang China 13 183 1.0× 72 0.5× 152 1.1× 17 0.2× 38 0.8× 37 621
Daisuke Shima Japan 14 72 0.4× 36 0.2× 270 2.0× 54 0.7× 26 0.5× 27 589
Wenhui Dong China 15 61 0.3× 125 0.8× 282 2.1× 10 0.1× 78 1.6× 31 579
Zhihong Xiao China 10 194 1.1× 41 0.3× 95 0.7× 36 0.5× 67 1.4× 40 469
Jae Kim South Korea 14 151 0.9× 35 0.2× 232 1.7× 36 0.5× 51 1.0× 24 648
J Fauvel France 14 82 0.5× 47 0.3× 317 2.4× 36 0.5× 32 0.7× 25 643
Xiulong Niu China 13 71 0.4× 106 0.7× 110 0.8× 23 0.3× 74 1.5× 26 381
Huynh Cao United States 13 126 0.7× 97 0.7× 211 1.6× 14 0.2× 65 1.3× 37 523
Ku-Geng Huo Canada 8 66 0.4× 67 0.4× 169 1.3× 20 0.3× 71 1.4× 13 425
Eduardo Martínez‐Ansó Spain 13 242 1.4× 48 0.3× 275 2.1× 16 0.2× 35 0.7× 21 866

Countries citing papers authored by Aurore Devocelle

Since Specialization
Citations

This map shows the geographic impact of Aurore Devocelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurore Devocelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurore Devocelle more than expected).

Fields of papers citing papers by Aurore Devocelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurore Devocelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurore Devocelle. The network helps show where Aurore Devocelle may publish in the future.

Co-authorship network of co-authors of Aurore Devocelle

This figure shows the co-authorship network connecting the top 25 collaborators of Aurore Devocelle. A scholar is included among the top collaborators of Aurore Devocelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurore Devocelle. Aurore Devocelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Yuan, Aurore Devocelle, Christophe Desterke, et al.. (2021). BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells. International Journal of Molecular Sciences. 22(10). 5247–5247. 30 indexed citations
2.
Devocelle, Aurore, Lola Lecru, Sophie Ferlicot, et al.. (2021). IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?. International Journal of Molecular Sciences. 22(21). 11698–11698. 14 indexed citations
3.
Zhang, Yuan, Aurore Devocelle, Lucas Eduardo Botelho de Souza, et al.. (2020). BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways. Aging. 12(9). 8067–8083. 20 indexed citations
4.
Devocelle, Aurore, Lola Lecru, Arnaud François, et al.. (2019). Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis. International Journal of Cell Biology. 2019. 1–15. 18 indexed citations
5.
Devocelle, Aurore, Aimé Vázquez, Claude Boucheix, et al.. (2016). IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process. Oncotarget. 7(50). 82511–82527. 29 indexed citations
6.
Lecru, Lola, Christophe Desterke, Stanislas Grassin‐Delyle, et al.. (2015). Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney International. 88(1). 72–84. 100 indexed citations
7.
Azzi, Sandy, Cindy Gallerne, Cristina Romei, et al.. (2015). Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions. Neoplasia. 17(6). 509–517. 9 indexed citations
8.
Giron‐Michel, Julien, Sandy Azzi, Erwan Mortier, et al.. (2012). Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the γc Signaling Pathway. PLoS ONE. 7(2). e31624–e31624. 23 indexed citations
9.
Azzi, Sandy, Stefania Bruno, Julien Giron‐Michel, et al.. (2011). Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15. JNCI Journal of the National Cancer Institute. 103(24). 1884–1898. 65 indexed citations
10.
Giron‐Michel, Julien, Sandy Azzi, Anne Caignard, et al.. (2011). Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancer. Bulletin du Cancer. 98(5). E32–E39. 4 indexed citations
11.
Giron‐Michel, Julien, Yanhong Gu, Aurélie Perier, et al.. (2009). Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition. Cancer Research. 69(4). 1561–1569. 40 indexed citations
12.
Giron‐Michel, Julien, F. Ménard, Simone Negrini, et al.. (2009). EBV-associated mononucleosis does not induce long-term global deficit in T-cell responsiveness to IL-15. Blood. 113(19). 4541–4547. 6 indexed citations
13.
Giuliani, Massimo, Julien Giron‐Michel, Simone Negrini, et al.. (2008). Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15. PLoS ONE. 3(5). e2241–e2241. 42 indexed citations
14.
Laforge, Mireille, Nicolas Bidère, Sylvie Carmona, et al.. (2006). Apoptotic Death Concurrent with CD3 Stimulation in Primary Human CD8+ T Lymphocytes: A Role for Endogenous Granzyme B. The Journal of Immunology. 176(7). 3966–3977. 25 indexed citations
15.
Bonhomme‐Faivre, Laurence, Aurore Devocelle, Faouzi Saliba, et al.. (2004). MDR-1 C3435T Polymorphism Influences Cyclosporine A Dose Requirement in Liver-Transplant Recipients. Transplantation. 78(1). 21–25. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026